Skip to main content
Caplight Logo









Biomede

Biomede

Private
VilleurbanneEnergy & Sustainabilityhttps://biomede.fr/en/welcome

Last Round

VC Round

Oct 20, 2022

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Biomede operates in Energy & Sustainability and is based in Villeurbanne. Its latest recorded funding round was a VC Round in October 2022.

Biomede is an agtech company that provides phytoextraction solutions to remove heavy metals from agricultural soils using specialized plants.

Sector

Energy & Sustainability

Verticals

Biotechnology, Circular Economy, Environmental Monitoring

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Biomede Comparables

Compare Biomede with similar companies based on industry and business-model similarity.

Biomede comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phyona Ltd
85%
RemePhy Technologies
78%
Novobiom
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Biomede Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 20, 2022
AcceleratorNov 1, 2018
SeedMar 22, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ludovic VINCENT

CEO Co-founder

Founding Team

For institutional investors. Book with your work email.

Biomede Investors

Notable investors and investment history

Biomede investors
InvestorRounds
50 PartnersAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 53% MoM.

  • May 15, 2026

    Monthly visitors grew 493% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Biomede Filings

Explore SEC and related filing metadata, where available.

Biomede filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Biomede's valuation, stock price, and market status.

Is Biomede a public or private company?

Biomede is a private company.

What is the current stock price of Biomede?

Biomede is a private company, so its shares have no public market price. Caplight tracks Biomede's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Biomede worth (valuation)?

Valuation information for Biomede is not publicly available.

Can I buy Biomede stock?

Biomede shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Biomede's last funding round?

Biomede's most recent funding round was VC Round on October 20, 2022.

Who are the main investors in Biomede?

Key investors in Biomede include 50 Partners.

Will Biomede IPO soon?

No public IPO plans have been announced for Biomede.

How can I track Biomede secondary market activity?

Caplight tracks bids, offers, and trades in Biomede's shares on secondary markets.

Firmographic Details

HeadquartersVilleurbanne
Employee Range3
Year Founded2017
Last FundingOct 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?